Webinar: Overview of Topline Results from Phase 3 EMBARK Study
PPMD was joined by Crystal Proud, MD for a community webinar on November 8th to discuss the recently shared Phase 3 topline results of the EMBARK study (SRP-9001-301). Siobhan Fitzgerald, Executive Director of Patient Affairs at Sarepta Therapeutics, also joined the webinar to answer frequently asked questions related to plans moving forward.
▶︎
Webinar: Avidity Biosciences - Topline Data from EXPLORE44® Clinical Trial
▶︎
Webinar: Capricor Therapeutics — HOPE-3 Community Update
▶︎
Management of Common Infections & Management of MDROs in Long Term Care.
▶︎
Advancements in Cell & Gene Therapy -- PPMD 2023 Annual Conference
▶︎
Navigating Cancer Immunotherapy: Exploring the World of mRNA Vaccines
▶︎
Transforming IT Operations in the Era of AI Agents
▶︎
‘Series of head spinning announcements’: Trump’s bluster fails to articulate end goal in Iran
▶︎
Full Webinar: The Light Adjustable Lens Platform
▶︎
Webinar: Sarepta Therapeutics - Community Update on ELEVIDYS
▶︎
RMIE 2022: Updates in Colon Cancer Screening
▶︎
Webinar: Capricor - Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy
▶︎
Webinar: Avidity Biosciences - EXPLORE44-OLE® Topline and Functional Data Presentation
▶︎
The skill of self confidence | Dr. Ivan Joseph | TEDxRyersonU
▶︎
12/10/24 Medicine Grand Rounds - Dr. Slawski
▶︎
Harm reduction in addiction recovery: Rogers Webinar April 2023
▶︎
Thoracic Outlet Syndrome: A Discussion with Brian D. Lewis, MD
▶︎
Webinar: Dyne Therapeutics — Topline Results from Phase 1/2 DELIVER Trial
▶︎
Managing Pain in Sickle Cell Disease:Challenges and Opportunities by A. Brandow et al|OPENPediatrics
▶︎
The Light Adjustable Lens Live Panel Discussion
▶︎